• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

39kDa 受体相关蛋白对 Abeta 聚集和神经毒性的抑制作用。

Inhibition of Abeta aggregation and neurotoxicity by the 39-kDa receptor-associated protein.

机构信息

Department of Biochemistry and Molecular Biology, School of Biomedical Sciences, Monash University, Victoria, Australia.

出版信息

J Neurochem. 2010 Mar;112(5):1199-209. doi: 10.1111/j.1471-4159.2009.06540.x. Epub 2009 Dec 10.

DOI:10.1111/j.1471-4159.2009.06540.x
PMID:20002523
Abstract

Aggregation of beta-amyloid protein (Abeta) to form oligomers is considered to be a key step in generating neurotoxicity in the Alzheimer's disease brain. Agents that bind to Abeta and inhibit oligomerization have been proposed as Alzheimer's disease therapeutics. In this study, we investigated the binding of fluorescein-labeled Abeta(1-42) (FluoAbeta(1-42)) to SH-SY5Y neuroblastoma cells and examined the effect of the 39-kDa receptor-associated protein (RAP), on the Abeta cell interaction. FluoAbeta(1-42) bound to the cells in a punctate pattern. Surprisingly, when RAP was added to the incubations, FluoAbeta(1-42) and RAP were found to be co-localized on the cell surface, suggesting that RAP and Abeta may bind to each other. Experiments using the purified proteins confirmed that a RAP-Abeta complex was stable and resistant to sodium dodecyl sulfate. RAP also inhibited Abeta oligomerization. We next examined whether RAP could inhibit the neurotoxic effects of Abeta. Addition of Abeta(1-42) to SH-SY5Y cells caused an increase in intracellular Ca2+ that was inhibited by treatment of the Abeta peptide with RAP. RAP also blocked an Abeta-induced inhibition of long-term memory consolidation in 1-day-old chicks. This study demonstrates that RAP binds to Abeta and is an inhibitor of the neurotoxic effects of Abeta.

摘要

β-淀粉样蛋白(Abeta)的聚集形成寡聚体被认为是在阿尔茨海默病大脑中产生神经毒性的关键步骤。已经提出了与 Abeta 结合并抑制寡聚化的药物作为阿尔茨海默病的治疗方法。在这项研究中,我们研究了荧光素标记的 Abeta(1-42)(FluoAbeta(1-42))与 SH-SY5Y 神经母细胞瘤细胞的结合,并检查了 39 kDa 受体相关蛋白(RAP)对 Abeta 细胞相互作用的影响。FluoAbeta(1-42)以点状模式与细胞结合。令人惊讶的是,当将 RAP 添加到孵育物中时,发现 FluoAbeta(1-42)和 RAP 在细胞表面上共定位,这表明 RAP 和 Abeta 可能相互结合。使用纯化蛋白进行的实验证实 RAP-Abeta 复合物是稳定的且耐受十二烷基硫酸钠。RAP 还抑制了 Abeta 的寡聚化。接下来,我们检查了 RAP 是否可以抑制 Abeta 的神经毒性作用。Abeta(1-42)添加到 SH-SY5Y 细胞中会导致细胞内 Ca2+增加,而用 RAP 处理 Abeta 肽可抑制这种增加。RAP 还阻止了 Abeta 诱导的 1 日龄小鸡长期记忆巩固的抑制。这项研究表明 RAP 与 Abeta 结合并且是 Abeta 神经毒性作用的抑制剂。

相似文献

1
Inhibition of Abeta aggregation and neurotoxicity by the 39-kDa receptor-associated protein.39kDa 受体相关蛋白对 Abeta 聚集和神经毒性的抑制作用。
J Neurochem. 2010 Mar;112(5):1199-209. doi: 10.1111/j.1471-4159.2009.06540.x. Epub 2009 Dec 10.
2
Development of a proteolytically stable retro-inverso peptide inhibitor of beta-amyloid oligomerization as a potential novel treatment for Alzheimer's disease.开发一种蛋白水解稳定的β-淀粉样寡聚体反向肽抑制剂作为治疗阿尔茨海默病的潜在新型药物。
Biochemistry. 2010 Apr 20;49(15):3261-72. doi: 10.1021/bi100144m.
3
Ectoine and hydroxyectoine inhibit aggregation and neurotoxicity of Alzheimer's beta-amyloid.四氢嘧啶和羟基四氢嘧啶可抑制阿尔茨海默病β-淀粉样蛋白的聚集和神经毒性。
FEBS Lett. 2005 Aug 29;579(21):4775-80. doi: 10.1016/j.febslet.2005.07.057.
4
Single chain variable fragments against beta-amyloid (Abeta) can inhibit Abeta aggregation and prevent abeta-induced neurotoxicity.抗β淀粉样蛋白(Abeta)的单链可变片段可抑制Abeta聚集并预防Abeta诱导的神经毒性。
Biochemistry. 2004 Jun 8;43(22):6959-67. doi: 10.1021/bi049933o.
5
S100B protects LAN-5 neuroblastoma cells against Abeta amyloid-induced neurotoxicity via RAGE engagement at low doses but increases Abeta amyloid neurotoxicity at high doses.S100B在低剂量时通过与晚期糖基化终末产物受体(RAGE)结合保护LAN - 5神经母细胞瘤细胞免受β淀粉样蛋白诱导的神经毒性,但在高剂量时会增加β淀粉样蛋白的神经毒性。
J Neurosci Res. 2006 Apr;83(5):897-906. doi: 10.1002/jnr.20785.
6
The beta-amyloid protein of Alzheimer's disease binds to membrane lipids but does not bind to the alpha7 nicotinic acetylcholine receptor.阿尔茨海默病的β-淀粉样蛋白与膜脂结合,但不与α7烟碱型乙酰胆碱受体结合。
J Neurochem. 2007 Jun;101(6):1527-38. doi: 10.1111/j.1471-4159.2006.04444.x. Epub 2007 Feb 5.
7
Amyloid-beta oligomers increase the localization of prion protein at the cell surface.淀粉样β寡聚体增加朊病毒蛋白在细胞表面的定位。
J Neurochem. 2011 May;117(3):538-53. doi: 10.1111/j.1471-4159.2011.07225.x. Epub 2011 Mar 23.
8
PP1 inhibition by Abeta peptide as a potential pathological mechanism in Alzheimer's disease.β-淀粉样肽对蛋白磷酸酶1的抑制作用作为阿尔茨海默病的一种潜在病理机制。
Neurotoxicol Teratol. 2009 Mar-Apr;31(2):85-8. doi: 10.1016/j.ntt.2008.11.001. Epub 2008 Nov 12.
9
Proteasome-mediated effects on amyloid precursor protein processing at the gamma-secretase site.蛋白酶体对γ-分泌酶位点淀粉样前体蛋白加工的影响。
Biochem J. 2005 Jan 15;385(Pt 2):545-50. doi: 10.1042/BJ20041145.
10
Mutated recombinant human glucagon-like peptide-1 protects SH-SY5Y cells from apoptosis induced by amyloid-beta peptide (1-42).突变的重组人胰高血糖素样肽-1可保护SH-SY5Y细胞免受β-淀粉样肽(1-42)诱导的细胞凋亡。
Neurosci Lett. 2008 Oct 31;444(3):217-21. doi: 10.1016/j.neulet.2008.08.047. Epub 2008 Aug 22.

引用本文的文献

1
Alzheimer's amyloid-β and tau protein accumulation is associated with decreased expression of the LDL receptor-associated protein in human brain tissue.阿尔茨海默病淀粉样β和tau 蛋白的积累与人类脑组织中 LDL 受体相关蛋白表达降低有关。
Brain Behav. 2020 Jul;10(7):e01672. doi: 10.1002/brb3.1672. Epub 2020 Jun 2.
2
Expression and Processing of Amyloid Precursor Protein in Vascular Endothelium.淀粉样前体蛋白在血管内皮中的表达与加工
Physiology (Bethesda). 2017 Jan;32(1):20-32. doi: 10.1152/physiol.00021.2016.